Literature DB >> 1533590

Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction.

C Platzer1, G Richter, K Uberla, W Müller, H Blöcker, T Diamantstein, T Blankenstein.   

Abstract

Interleukin (IL)-4-transgenic mice were used as a model system to study the consequences of low levels of IL-4 expression for the expression of other cytokines examined by quantitative polymerase chain reaction (PCR). For this purpose, a plasmid was constructed which contains, in tandem array, 5' and 3' primer sequences specific for the cytokine genes IL-1 to IL-6, tumor necrosis factor (TNF), lymphotoxin (LT), interferon (IFN)-gamma and beta-actin. During co-amplification, target and control DNA compete for the primers and the amount of PCR product is proportional to the amount of input DNA. Competitive PCR was performed first to adjust the cDNA to be compared to identical concentrations of beta-actin cDNA and subsequently to determine cytokine mRNA levels from spleen cells of normal and IL-4-transgenic animals. The sensitivity of this approach was demonstrated by the capability to detect a twofold difference in IL-4 mRNA levels between IL-4-transgenic heterozygous and homozygous animals. Upon lipopolysaccharide activation, the IL-4 transgene which is expressed essentially in B lymphocytes was induced approximately 50-fold. Several cytokine mRNA such as those coding for IL-5, IL-6, IFN-gamma and also the IL-4 receptor were found to be up-regulated in IL-4-transgenic mice, whereas IL-1, IL-2, IL-3, TNF and LT mRNA levels did not seemed to be influenced by IL-4. A possible functional significance of the elevated IFN-gamma mRNA was demonstrated by showing that (a) CD23 expression was not increased, and (b) Mac-1+ cells were markedly increased in the spleen of transgenic mice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533590     DOI: 10.1002/eji.1830220511

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  31 in total

1.  Applications of competitor RNA in diagnostic reverse transcription-PCR.

Authors:  Steven B Kleiboeker
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Functional difference between Thy-1-positive and Thy-1-negative gamma delta T cells induced by Escherichia coli infection in mice.

Authors:  H Takada; G Matsuzaki; H Yoshida; H Sumichika; K Nomoto
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

Review 3.  Transgenic mice in the study of cytokine function.

Authors:  J Taverne
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

4.  Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation.

Authors:  I B Autenrieth; N Bucheler; E Bohn; G Heinze; I Horak
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

5.  CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells.

Authors:  J Morales; B Homey; A P Vicari; S Hudak; E Oldham; J Hedrick; R Orozco; N G Copeland; N A Jenkins; L M McEvoy; A Zlotnik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

6.  Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease.

Authors:  R G Titus; G K DeKrey; R V Morris; M B Soares
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

7.  Gamma delta T cells in infection-induced and autoimmune-induced testicular inflammation.

Authors:  A Mukasa; H Yoshida; N Kobayashi; G Matsuzaki; K Nomoto
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

8.  Induction of cytokines in phagocytic mammalian cells infected with virulent and avirulent Listeria strains.

Authors:  M Kuhn; W Goebel
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

9.  Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.

Authors:  K Yamamoto; D J Loskutoff
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Interleukin-4 enhances interferon-gamma synthesis but inhibits development of interferon-gamma-producing cells.

Authors:  A Noble; D M Kemeny
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.